ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Middle East

COVID-19: UAE stamps on use of Sinopharm vaccine among 3-17 year age group

Abu Dhabi [UAE] August 3 (ANI): The United Arab Emirates on Monday approved the use of Sinopharm vaccine for 3-17 age group against COVID-19 virus.

ANI Aug 03, 2021 00:35 IST googleads

Representative image

Abu Dhabi [UAE] August 3 (ANI): The United Arab Emirates on Monday approved the use of Sinopharm vaccine for 3-17 age group against COVID-19 virus.
The decision is taken based on the clinical studies, the strict assessment to approve the emergency use of this vaccine and the local evaluation that complies with the approved regulations, Gulf News reported.
This decision will help UAE to further ramp up its fight against the COVID-19 pandemic.
"Research so far has shown that COVID-19 vaccines are remarkably effective and safe. In addition, children have been safely receiving vaccines for multiple diseases and viruses for generations. The Sinopharm vaccine is similar in concept to all of these vaccines," Dr Ahmed Alsuwaidi, Associate Professor of Paediatrics and Infectious Diseases, at the United Arab Emirates University said during the launch of Sinopharm.
Meanwhile, more than 64 per cent of the UAE population have been vaccinated, the country has administered more than 15.5 million doses of COVID-19 vaccines.
Earlier, the Sputnik V was also registered in UAE in January 2021 under the emergency use authorisation procedure.
The Russian Direct Investment Fund also announced that the efficacy of Sputnik V in the United Arab Emirates (UAE) was confirmed at 97.8 per cent among over 81,000 people. (ANI)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Middle East

UAE hails UNSC resolution condemning unprovoked Iranian strikes 

UAE hails UNSC resolution condemning unprovoked Iranian strikes 

The UAE has led a successful UN diplomatic push, with the Security Council adopting Resolution 2817 to condemn Iran's "egregious attacks." Co-sponsored by 140 nations, the resolution demands an end to "indiscriminate strikes" and affirms the UAE's right to self-defence against threats to its sovereignty and civilian infrastructure.

Read More
Middle East

UAE activates air defences to counter missile threat

UAE activates air defences to counter missile threat

The UAE has activated air defences to intercept an Iranian missile and drone attack, advising residents to "remain in a safe location." Authorities have intercepted over 1,700 threats since the conflict began. While most were neutralised, hostilities have tragically caused six deaths and 131 injuries among various nationalities.

Read More
Asia

India assisting return of its citizens from Iran via land routes

India assisting return of its citizens from Iran via land routes

MEA official spokesperson Randhir Jaiswal, while addressing an Inter-Ministerial Briefing on Recent Developments in West Asia, said that the Indian Embassy in Tehran remains fully operational and is on high alert. The government is assisting Indian nationals, including students and pilgrims, who wish to leave the country. He further added that those choosing to exit Iran via land, the embassy is assisting citizens in crossing into Armenia and Azerbaijan, from where they can board commercial flights to return to India.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.